Multiple Sclerosis Clinical Trial

PTNS on Urinary and Global Quality of Life in MS Patients

Summary

This is a single-centered, prospective, longitudinal, observational cohort study of patients with MS who suffer from lower urinary tract symptoms (LUTS) and are refractory to two prior treatment modalities who have elected to pursue PTNS therapy for LUTS.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of Multiple Sclerosis
Lower urinary tract symptoms (urinary frequency, urgency and/or incontinence)
Failed prior first and second line therapy (behavioral and pharmacotherapy)
Electing for Posterior Tibial Nerve Stimulation therapy for urinary symptoms
Patients performing Intermittent Catheterization are Eligible

Exclusion Criteria:

Indwelling catheters (urethral or suprapubic)
Currently pregnant or planning pregnancy
Unable to attend weekly office visits for PTNS
Urodynamic findings of bladder outlet obstruction

History of:

bladder reconstruction (augmentation cystoplasty, catheterizable channel) cystectomy bladder stones pacemaker or defibrillator malignancy of bladder sacral neuromodulation intravesical injection of onabotulinum toxin within 9 months

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

23

Study ID:

NCT04063852

Recruitment Status:

Completed

Sponsor:

University of Michigan

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Michigan
Ann Arbor Michigan, 48109, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

23

Study ID:

NCT04063852

Recruitment Status:

Completed

Sponsor:


University of Michigan

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.